World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
57958
World Ranking
9075
National Ranking
4681

Overview

David J. Moliterno is affiliated with the University of Kentucky in the United States. Their research primarily focuses on medicine, with specializations in cardiology and cardiovascular medicine, surgery, radiology, nuclear medicine and imaging, internal medicine, and public health, environmental and occupational health.

The scientist's work is concentrated on several main topics:

  • Antiplatelet Therapy and Cardiovascular Diseases
  • Coronary Interventions and Diagnostics
  • Acute Myocardial Infarction Research
  • Lipoproteins and Cardiovascular Health
  • Atrial Fibrillation Management and Outcomes
  • Cardiac, Anesthesia and Surgical Outcomes
  • Venous Thromboembolism Diagnosis and Management

The recent publications by David J. Moliterno include:

  • Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention, 2021, Circulation
  • Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS, 2020, European Heart Journal
  • Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR, 2021, European Heart Journal
  • Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention, 2021, JAMA Cardiology
  • Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention, 2020, Circulation Cardiovascular Interventions

Frequent co-authors of Moliterno include:

  • Roxana Mehran
  • George Dangas
  • Samantha Sartori
  • Dominick J. Angiolillo
  • Javier Escaned

The scientist's work has been published extensively in various venues, with the most frequent being:

  • JACC: Cardiovascular Interventions
  • European Heart Journal
  • Journal of the American College of Cardiology
  • Catheterization and Cardiovascular Interventions
  • The American Journal of Cardiology

Best Publications

  • Third universal definition of myocardial infarction

    Kristian Thygesen;Joseph S. Alpert;Allan S. Jaffe;Maarten L. Simoons

  • Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery Stents A Science Advisory From the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, With Representation From the American College of Physicians

    Cindy L. Grines;Robert O. Bonow;Donald E. Casey;Timothy J. Gardner

  • 2012 ACCF/AATS/SCAI/STS Expert Consensus Document on Transcatheter Aortic Valve Replacement

    David R. Holmes;Michael J. Mack;Sanjay Kaul;Arvind Agnihotri

  • Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

    Eric Boersma;Robert A Harrington;David J Moliterno;Harvey White

  • Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes.

    Sunil V. Rao;James G. Jollis;Robert A. Harrington;Christopher B. Granger

  • ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents

    W. Gregory Hundley;David A. Bluemke;J. Paul Finn;Scott D. Flamm

  • Randomized, Placebo-Controlled Trial of Platelet Glycoprotein IIb/IIIa Blockade With Primary Angioplasty for Acute Myocardial Infarction

    S. J. Brener;L. A. Barr;J. E. B. Burchenal;S. Katz

  • Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes

    Pierluigi Tricoci;Zhen Huang;Claes Held;David J. Moliterno

  • Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.

    E J Topol;D J Moliterno;H C Herrmann;E R Powers

  • Ticagrelor with or without Aspirin in High-Risk Patients after PCI

    Roxana Mehran;Usman Baber;Samin K Sharma;David J Cohen

  • ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents

    Deepak L. Bhatt;James Scheiman;Neena S. Abraham;Elliott M. Antman

  • Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.

    Roxana Mehran;Usman Baber;Philippe Gabriel Steg;Cono Ariti

  • Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction

    Koon-Hou Mak;David J. Moliterno;Christopher B. Granger;Dave P. Miller

  • ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: A focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents

    Neena S. Abraham;Mark A. Hlatky;Elliott M. Antman;Deepak L. Bhatt

  • Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes

    Marco Roffi;Derek P. Chew;Debabrata Mukherjee;Deepak L. Bhatt

  • Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery Stents. A Science Advisory From the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association

    Cindy L. Grines;Robert O. Bonow;Donald E. Casey;Timothy J. Gardner

  • Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.

    Usman Baber;Roxana Mehran;Gennaro Giustino;David J. Cohen

  • Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention

    Dirk Sibbing;Daniel Aradi;Dimitrios Alexopoulos;Jurrien ten Berg

  • Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention Results of the GOLD (AU-Assessing Ultegra) Multicenter Study

    Steven R. Steinhubl;J. David Talley;Gregory A. Braden;James E. Tcheng

  • ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents.

    L. Kristin Newby;Robert L. Jesse;Joseph D. Babb;Robert H. Christenson

Frequent Co-Authors

Eric J. Topol
Eric J. Topol Scripps Research Institute
Robert A. Harrington
Robert A. Harrington Cornell University
Paul W. Armstrong
Paul W. Armstrong University of Alberta
Harvey D. White
Harvey D. White Auckland City Hospital
Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University
Robert M. Califf
Robert M. Califf Duke University
Debabrata Mukherjee
Debabrata Mukherjee Texas Tech University Health Sciences Center
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Christopher B. Granger
Christopher B. Granger Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in a healthcare career but seeking alternatives to traditional medical school, there are many flexible options to consider. Online programs in healthcare are designed for students at different educational and professional levels, offering convenience without sacrificing quality.

For those considering management roles in healthcare settings, online health administration programs make it possible to develop leadership skills and gain industry knowledge entirely online. Nurses who wish to advance their education and career may benefit from adn to msn bridge programs, which allow registered nurses to earn a master’s degree efficiently.

Nutrition is another growing field. Students interested in promoting wellness or working as nutrition experts can pursue a bachelor's in nutrition online, learning essential skills for diverse careers such as dietetics or public health. If you plan to move into higher-level administration, it’s smart to explore accredited mha programs that focus on healthcare management and policy.

These online degrees and bridge programs offer flexible pathways to rewarding roles in healthcare—whether your goals involve direct patient care, administration, or fostering healthier communities.

Best Scientists Citing David J. Moliterno

Trending Scientists

Recently Published Articles